The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...

E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing ...

Inhibikase Therapeutics (IKT) appointed Mark Iwicki as the company’s CEO, replacing Milton Werner, founder of Inhibikase, effective February ...

JPMorgan Chase JPM.N said on Thursday that long-serving CEO Jamie Dimon's 2024 pay package climbed about 8.3% to $39 million after the bank posted a record profit amid a revival in dealmaking ...

In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now ...

In turn, this could actually bring a new wave of long-term growth for Nvidia. Palantir CEO Alex Karp recently shared some interesting thoughts on the DeepSeek development. Alex Karp is a PhD., ...

The Super Bowl is three days away and Novartis is gearing up for its advertising debut at the big game. The Swiss drugmaker announced last week that it will air a 60-second ad during Super Bowl LIX to ...

Novartis has set a high bar for any potential obesity-treatment acquisition as it scans the market for deals to fill its drug pipeline and power sales growth into the 2030s, its chief executive said.

Novartis (NVS) CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if its main focus remains on therapeutic areas where it ...

NEW ORLEANS -- Philadelphia Eagles chairman and CEO Jeffrey Lurie said Monday he is not pursuing an ownership stake in the NBA'sBoston Celtics, disputing a report. "I'm not really interested in ...